The acquired immunodeficiency syndrome (AIDS) has become a global pandemic, with cases reported in 138 countries throughout the world. An intensive research effort has been undertaken in several countries in the Caribbean and Africa to study the unique epidemiologic, virologic, clinical, an immunologic features of AIDS in these areas. In Kinshasa, Zaire, we identified over 10,000 cases of AIDS in 1987 with a male to female ration of 1:1.5. The disease is predominantly heterosexually transmitted with high seroprevalence rates to the human immunodeficiency virus (HIV) of 3-6% among the general heterosexual population in Kinshasa in contrast to <1% in rural Africa. HIV infection rates of 20-80% have been documented among spouses of AIDS patients, female prostitutes, and among patients attending STD clinics. Similar studies in the U.S. have confirmed a 5% infection rate among patients attending STD clinics with increasing evidence of heterosexual transmission among these patients. The presence f genital ulcerations were significantly associated with heterosexual transmission. In studies of perinatal transmission of HIV infection, over 15,000 pregnant women in Haiti, Kenya, and Zaire, of whom approximately 6% are HIV seropositive have been enrolled in prospective studies. Perinatal transmission which occurs in approximately 50% of children appears to correlate with advanced clinical disease and immunologic impairment of the mother with depressed T4 cells. Perinatal HIV was associated with premature birth, low birth weight, and an increased mortality (22%) within the first year of life. Childhood immunization studies on HIV infected children demonstrated efficacy of most vaccines with few adverse effects, documenting the continual need form complete immunization programs. Immunologic studies have confirmed the development of HIV-1 specific antibody dependent cellular cytotoxicity (ADCC) in HIV infected African patients which correlated strongly with the development of antibody to gp41. Further studies will continue to examine the frequency of human retroviral infection (HIV-1, HIV-2, HTLV-1) in selected populations with particular emphasis on natural history, perinatal transmission, and immunopathognesis which might have relevance to future vaccine studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000361-07
Application #
3818211
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Meya, David; Spacek, Lisa A; Tibenderana, Hilda et al. (2009) Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria. J Int AIDS Soc 12:3
Johnson, Kristine E; Quinn, Thomas C (2008) Update on male circumcision: prevention success and challenges ahead. Curr Infect Dis Rep 10:243-51
Blake, Diane R; Maldeis, Nancy; Barnes, Mathilda R et al. (2008) Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting. Sex Transm Dis 35:649-55
Chang, Larry William; Kagaayi, Joseph; Nakigozi, Gertrude et al. (2008) Telecommunications and health Care: an HIV/AIDS warmline for communication and consultation in Rakai, Uganda. J Int Assoc Physicians AIDS Care (Chic) 7:130-2
Blake, Diane R; Quinn, Thomas C; Gaydos, Charlotte A (2008) Should asymptomatic men be included in chlamydia screening programs? Cost-effectiveness of chlamydia screening among male and female entrants to a national job training program. Sex Transm Dis 35:91-101
NIMH Collaborative HIV/STD Prevention Trial Group (2007) Formative study conducted in five countries to adapt the community popular opinion leader intervention. AIDS 21 Suppl 2:S91-8
NIMH Collaborative HIV/STD Prevention Trial Group (2007) Sexually transmitted disease and HIV prevalence and risk factors in concentrated and generalized HIV epidemic settings. AIDS 21 Suppl 2:S81-90
NIMH Collaborative HIV/STD Prevention Trial Group (2007) The community popular opinion leader HIV prevention programme: conceptual basis and intervention procedures. AIDS 21 Suppl 2:S59-68
NIMH Collaborative HIV/STD Prevention Trial Group (2007) Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial. AIDS 21 Suppl 2:S69-80
NIMH Collaborative HIV/STD Prevention Trial (2007) Role of the data safety and monitoring board in an international trial. AIDS 21 Suppl 2:S99-102

Showing the most recent 10 out of 123 publications